Pan‐Chyr Yang
University of Electronic Science and Technology of China(CN)Army Medical University(CN)National Taiwan University of Science and Technology(TW)China West Normal University(CN)National Taiwan University(TW)Dalian Medical University(CN)Sichuan University(CN)Guangzhou Institutes of Biomedicine and Health(CN)Southwest Medical University(CN)China University of Geosciences(CN)Genomics Research Center, Academia Sinica(TW)West China Hospital of Sichuan University(CN)Guangzhou Experimental Station(CN)Ganzhou People's Hospital(CN)Institute of Biomedical Sciences, Academia Sinica(TW)Second Affiliated Hospital of Chongqing Medical University(CN)Zhejiang Industry Polytechnic College(CN)Sichuan Cancer Hospital(CN)Zhujiang Hospital(CN)Mayo Clinic in Arizona(US)First Affiliated Hospital of Chongqing Medical University(CN)National Taiwan University Hospital(TW)Changsha Hospital for Maternal and Child Health Care(CN)Intelligent Health (United Kingdom)(GB)Chongqing Cancer Hospital(CN)Hunan Provincial Maternal and Child Health Hospital(CN)National Taipei University of Business(TW)Southern Medical University(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, RNA modifications and cancer, Lung Cancer Research Studies, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma(2011)4,802 cited
- → MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited
- → A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)(2014)1,525 cited
- → A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer(2007)948 cited
- → MicroRNA Signature Predicts Survival and Relapse in Lung Cancer(2008)782 cited
- → International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary